Literature DB >> 7082865

In vivo cell kinetic effects of vincristine on the spontaneous AKR leukemia: recruitment of non-proliferating cells.

K Hiller, P Meyer, K Wilms.   

Abstract

In order to investigate the influence of a cell-cycle specific agent on the cytokinetic behavior of a leukemic cell population in vivo, labeling studies with tritiated thymidine (3HTDR) followed by administration of vincristine (VCR) were performed on thymic cells of advanced AKR leukemic mice and evaluated utilizing a combined autoradiographic-Feulgen-microspectrophotometric technique. Twelve hours after a single drug injection the stathmokinetic effect of VCR was observed as reflected by an accumulation of cells in the S/G2-M phase of the mitotic cycle. Within 28 h this effect was no longer evident, but the significant increase in % unlabeled S/G2-M cells strongly suggested an influx of previously non-proliferating cells into the proliferating compartment (recruitment).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082865     DOI: 10.1007/BF00320497

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  23 in total

1.  The action of the vincaleukolastine on mitosis in vitro.

Authors:  C G PALMER; D LIVENGOOD; A K WARREN; P J SIMPSON; I S JOHNSON
Journal:  Exp Cell Res       Date:  1960-06       Impact factor: 3.905

2.  Kinetics of lymphocytes in Hodgkin's disease.

Authors:  P Schick; F Trepel; H Theml; S Benedek; P Trumpp; W Kaboth; H Begemann; T M Fliedner
Journal:  Blut       Date:  1973-10

3.  Perturbation of generation cycle of human leukemic myeloblasts in vivo by methotrexate.

Authors:  P Ernst; S A Killmann
Journal:  Blood       Date:  1971-12       Impact factor: 22.113

4.  Attempted recruitment of leukemic myeloblasts to proliferative activity by sequential drug treatment.

Authors:  P J Burke; A H Owens
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

5.  Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells.

Authors:  H Madoc-Jones; F Mauro
Journal:  J Cell Physiol       Date:  1968-12       Impact factor: 6.384

6.  Vincristine (NSC-67574) symposium--summary and prospectives.

Authors:  J G Armstron
Journal:  Cancer Chemother Rep       Date:  1968-06

7.  Historical background of Vinca alkaloid research and areas of future interest.

Authors:  I S Johnson
Journal:  Cancer Chemother Rep       Date:  1968-06

8.  In vitro combination chemotherapy demonstrating potentiation of vincristine cytotoxicity by prednisolone.

Authors:  F Rosner; Y Hirshaut; H W Grünwald; M Dietrich
Journal:  Cancer Res       Date:  1975-03       Impact factor: 12.701

Review 9.  Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971.

Authors:  H E Skipper; F M Schabel; M W Trader; W R Laster; L Simpson-Herren; H H Lloyd
Journal:  Cancer Chemother Rep       Date:  1972-06

10.  Drug effect in acute leukemia.

Authors:  B C Lampkin; T Nagao; A M Mauer
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

View more
  1 in total

1.  Tumor cell recruitment in the mouse adenocarcinoma EO 771 directly demonstrated by double labeling with [3H]- and [14C] thymidine and flow cytometry.

Authors:  J Walter; B Maurer-Schultze
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.